Rainer Wessel

Venture Partner at EMBL Ventures GmbH

Rainer Wessel

Rainer Wessel

Venture Partner at EMBL Ventures GmbH

Biography

Rainer Wessel occupies the position of Venture Partner at EMBL Ventures GmbH. In the past he held the position of President & Chief Executive Officer for Axxima Pharmaceuticals AG, Chief Business Officer & Executive Speaker at Ganymed Pharmaceuticals AG and Principal at QIAGEN GmbH.

Overview
Career Highlights

Axxima Pharmaceuticals AG

RelSci Relationships

64

Birthday

09/1960

Age

60

Relationships
RelSci Relationships are individuals Rainer Wessel likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Advisor at EMBL Ventures GmbH

Relationship likelihood: Strong

Founding Partner at EMBL Ventures GmbH

Relationship likelihood: Strong

Head-Chemical Biology at The European Molecular Biology Laboratory

Relationship likelihood: Strong

Head of Resource Development at The European Molecular Biology Laboratory

Relationship likelihood: Strong

Director General at The European Molecular Biology Laboratory

Relationship likelihood: Strong

Venture Partner at EMBL Ventures GmbH

Relationship likelihood: Strong

Managing Director at EMBL Ventures GmbH

Relationship likelihood: Strong

Chief Executive Officer & Co-Founder at Sloning Bio Technology GmbH

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Amphivena Therapeutics, Inc.

Relationship likelihood: Average

Co-Founder at vasopharm GmbH

Relationship likelihood: Average

Paths to Rainer Wessel
Potential Connections via
Relationship Science
You
Rainer Wessel
Venture Partner at EMBL Ventures GmbH
Career History
President & Chief Executive Officer
Prior

Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany.

Professional
Prior

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Venture Partner
Current

EMBL Ventures is a hands-on, long-term manager which invests in disruptive biology and life-science related products and technologies with global potential, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics developed at the EMBL, from EMBL alumni and from non-EMBL third parties.The firm seeks to invest in entrepreneurial management teams with: a combination of relevant technical expertise, drive, business sense and a down-to-earth attitude; ownership of a proprietary core or platform technology generating a proprietary position or clear competitive advantage in a defined market sector and a solution for a problem with a significant advantage in a market of substantial size and the chance to achieve a leading, sustainable market position.EMBL Ventures typically acts as the lead or co-lead investor for initial financing and also participates in follow-up financing. They partner with their investee companies, taking a seat on the board of directors. To maximize the intrinsic value of a technology or product, the firm's investment strategy targets one of the main value inflection points, typically the transition from early development or conceptual stage up to proof of concept.

Other Affiliations

Rainer Wessel is affiliated with Axxima Pharmaceuticals AG, QIAGEN GmbH, EMBL Ventures GmbH

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Rainer Wessel. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Rainer Wessel's profile does not indicate a business or promotional relationship of any kind between RelSci and Rainer Wessel.